Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease

Dan Li,Cong Liu

DOI: https://doi.org/10.1038/s41589-020-00708-z

IF: 14.8

2021-01-11

Nature Chemical Biology

Abstract:Amyloid aggregation, which disrupts protein homeostasis, is a common pathological event occurring in human neurodegenerative diseases (NDs). Numerous evidences have shown that the structural diversity, so-called polymorphism, is decisive to the amyloid pathology and is closely associated with the onset, progression, and phenotype of ND. But how could one protein form so many stable structures? Recently, atomic structural evidence has been rapidly mounting to depict the involvement of chemical modifications in the amyloid fibril formation. In this Perspective, we aim to present a hierarchical regulation of chemical modifications including covalent post-translational modifications (PTMs) and noncovalent cofactor binding in governing the polymorphic amyloid formation, based mainly on the latest α-synuclein and Tau fibril structures. We hope to emphasize the determinant role of chemical modifications in amyloid assembly and pathology and to evoke chemical biological approaches to lead the fundamental and therapeutic research on protein amyloid state and the associated NDs.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **How is the structural diversity (i.e., polymorphism) of protein amyloid aggregation determined?**

Specifically, the paper focuses on the fact that in neurodegenerative diseases, the fibrillar structures formed by protein amyloid aggregation are highly diverse. This diversity is not only reflected in different diseases, but also exists among different patients with the same disease. This structural polymorphism is considered to be closely related to the pathogenesis, progression mode, and clinical manifestations of the disease. However, at present, the specific formation mechanisms of these polymorphic fibrillar structures are not fully understood.

The paper proposes that chemical modifications (including covalent post - translational modifications and non - covalent cofactor binding) play a key role in the formation of polymorphism in amyloid fibrils. By analyzing the recently reported high - resolution amyloid fibril structures, especially the fibril structures of α - synuclein and Tau protein, the authors explored how these chemical modifications regulate the formation of amyloid fibrils at the molecular level. The paper also discussed the hierarchical regulatory roles of different types of chemical modifications in amyloid fibril assembly, including:

1. **Class I modifications**: These modifications are located inside the fibril core, can define protein folding, and affect the initial steps of fibril assembly.
2. **Class II and Class III modifications**: These modifications are located on the outer surface of the fibril core, can select fibril polymorphism, and change the physical and chemical properties of the fibril core.
3. **Class IV modifications**: These modifications occur on residues that do not belong to the fibril core. Their influence on fibril assembly is uncertain, but they may affect conformational selection and the helical extension of fibrils.

Through these analyses, the paper aims to emphasize the decisive role of chemical modifications in amyloid protein assembly and pathology, and advocates the use of chemical biology methods to promote the development of relevant basic research and treatment research.